Up- and down-regulated genes in DLBCL patients with CXCR4+ and CXCR4− expression and an IPI≤2 (false discovery rate threshold: .01; P value cutoff: .000058; fold change cutoff: 1.57). This evidence concerns the gene CXCR4 and diffuse large B-cell lymphoma.